Name | FATP1-IN-2 |
---|
Description | FATP1-IN-2, as an arylpiperazine derivative, is an orally active fatty acid transport protein 1 (FATP1) inhibitor (human IC50=0.43 μM, mouse IC50=0.39 μM)[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.43 μM (human FATP1)[1]. IC50: 0.39 μM (mouse FATP1)[1] |
In Vivo | FATP1-IN-2 (10 mg/kg; p.o.) shows a Cmax value above the mouse IC50 value[1]. FATP1-IN-2 (3, 10, 30 mg/kg; p.o.; 4 weeks) shows TG content of each tissue does not change at any dose[1]. Animal Model: Mice[1] Dosage: 10 mg/kg Administration: P.o. Result: Showed a Cmax value above the mouse IC50 value. |
References |
Molecular Formula | C19H20FN5O |
---|---|
Molecular Weight | 353.39 |